Rockefeller Capital Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-16,705
| Closed | -$240K | – | 1737 |
|
|
2024
Q4 | $240K | Sell |
16,705
-799
| -5% | -$11.5K | ﹤0.01% | 1627 |
|
|
2024
Q3 | $395K | Buy |
17,504
+4,746
| +37% | +$107K | ﹤0.01% | 1500 |
|
|
2024
Q2 | $248K | Sell |
12,758
-1,288
| -9% | -$25.1K | ﹤0.01% | 1593 |
|
|
2024
Q1 | $527K | Sell |
14,046
-4,374
| -24% | -$164K | ﹤0.01% | 1456 |
|
|
2023
Q4 | $1.03M | Buy |
18,420
+7,762
| +73% | +$434K | ﹤0.01% | 1130 |
|
|
2023
Q3 | $440K | Sell |
10,658
-1,006
| -9% | -$41.5K | ﹤0.01% | 1321 |
|
|
2023
Q2 | $651K | Buy |
11,664
+1,165
| +11% | +$65.1K | ﹤0.01% | 1243 |
|
|
2023
Q1 | $584K | Sell |
10,499
-1,562
| -13% | -$86.9K | ﹤0.01% | 1286 |
|
|
2022
Q4 | $439K | Buy |
12,061
+9,186
| +320% | +$334K | ﹤0.01% | 1330 |
|
|
2022
Q3 | $81K | Buy |
2,875
+1,402
| +95% | +$39.5K | ﹤0.01% | 2110 |
|
|
2022
Q2 | $66K | Sell |
1,473
-3,835
| -72% | -$172K | ﹤0.01% | 2165 |
|
|
2022
Q1 | $402K | Buy |
5,308
+59
| +1% | +$4.47K | ﹤0.01% | 1403 |
|
|
2021
Q4 | $781K | Buy |
5,249
+921
| +21% | +$137K | ﹤0.01% | 1140 |
|
|
2021
Q3 | $629K | Sell |
4,328
-14,837
| -77% | -$2.16M | ﹤0.01% | 1176 |
|
|
2021
Q2 | $3.75M | Buy |
19,165
+9,534
| +99% | +$1.87M | 0.02% | 530 |
|
|
2021
Q1 | $1.74M | Sell |
9,631
-3,228
| -25% | -$584K | 0.01% | 621 |
|
|
2020
Q4 | $1.82M | Buy |
12,859
+2,639
| +26% | +$373K | 0.01% | 545 |
|
|
2020
Q3 | $1.27M | Buy |
10,220
+8,312
| +436% | +$1.03M | 0.01% | 536 |
|
|
2020
Q2 | $170K | Sell |
1,908
-309
| -14% | -$27.5K | ﹤0.01% | 1000 |
|
|
2020
Q1 | $138K | Buy |
+2,217
| New | +$138K | ﹤0.01% | 921 |
|